Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

VALDENAIRE

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
The Journal of Biological Chemistry|July 10, 1999
Neonatal lethality in mice deficient in XCE, a novel member of the endothelin-converting enzyme and neutral endopeptidase familyA Schweizer, O Valdenaire, A Köster, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|June 1, 1977
[Treatment of amenorrhea-galactorrhea with bromo-ergocryptine. Apropos of 12 cases]P Hartemann, J Leclere, M Groussin, et al.
The Journal of Physical Chemistry. B|June 28, 2019
Methane Diffusion in a Flexible Kerogen MatrixAmaël Obliger, Pierre-Louis Valdenaire, Franz-Josef Ulm, et al.
Personality and Mental Health|January 8, 2025
Description of Borderline Personality Disorder Hospitalizations for Adolescents and Adults in France Between 2013 and 2022: A Nationwide Retrospective StudyFlorian Dufrenois, Chloé Saint-Dizier, Salomé Veltz, et al.
Cell and Tissue Research|February 27, 1999
The endothelin system in human and monkey ovaries: in situ gene expression of the different componentsH Karam, O Valdenaire, M F Belair, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2013
Evolution of novel tricyclic CRTh2 receptor antagonists from a (E)-2-cyano-3-(1H-indol-3-yl)acrylamide scaffoldAnja Valdenaire, Julien Pothier, Dorte Renneberg, et al.
European Journal of Biochemistry|September 22, 1999
A fourth isoform of endothelin-converting enzyme (ECE-1) is generated from an additional promoter molecular cloning and characterizationO Valdenaire, D Lepailleur-Enouf, G Egidy, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 25, 2019
[Liver stereotactic body radiotherapy: Clinical features and technical consequences, results. Which treatment machine in which situation?]O Riou, S Valdenaire, P Debuire, et al.
Journal of Medicinal Chemistry|June 1, 2013
Identification of 2-(2-(1-naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic acid (setipiprant/ACT-129968), a potent, selective, and orally bioavailable chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) antagonistHeinz Fretz, Anja Valdenaire, Julien Pothier, et al.
The Journal of Chemical Physics|January 17, 2020
Timescale prediction of complex multi-barrier pathways using flux sampling molecular dynamics and 1D kinetic integration: Application to cellulose dehydrationPierre-Louis Valdenaire, Roland J M Pellenq, Franz J Ulm, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|July 10, 1999
Neonatal lethality in mice deficient in XCE, a novel member of the endothelin-converting enzyme and neutral endopeptidase familyA Schweizer, O Valdenaire, A Köster, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|June 1, 1977
[Treatment of amenorrhea-galactorrhea with bromo-ergocryptine. Apropos of 12 cases]P Hartemann, J Leclere, M Groussin, et al.
The Journal of Physical Chemistry. B|June 28, 2019
Methane Diffusion in a Flexible Kerogen MatrixAmaël Obliger, Pierre-Louis Valdenaire, Franz-Josef Ulm, et al.
Personality and Mental Health|January 8, 2025
Description of Borderline Personality Disorder Hospitalizations for Adolescents and Adults in France Between 2013 and 2022: A Nationwide Retrospective StudyFlorian Dufrenois, Chloé Saint-Dizier, Salomé Veltz, et al.
Cell and Tissue Research|February 27, 1999
The endothelin system in human and monkey ovaries: in situ gene expression of the different componentsH Karam, O Valdenaire, M F Belair, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2013
Evolution of novel tricyclic CRTh2 receptor antagonists from a (E)-2-cyano-3-(1H-indol-3-yl)acrylamide scaffoldAnja Valdenaire, Julien Pothier, Dorte Renneberg, et al.
European Journal of Biochemistry|September 22, 1999
A fourth isoform of endothelin-converting enzyme (ECE-1) is generated from an additional promoter molecular cloning and characterizationO Valdenaire, D Lepailleur-Enouf, G Egidy, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 25, 2019
[Liver stereotactic body radiotherapy: Clinical features and technical consequences, results. Which treatment machine in which situation?]O Riou, S Valdenaire, P Debuire, et al.
Journal of Medicinal Chemistry|June 1, 2013
Identification of 2-(2-(1-naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic acid (setipiprant/ACT-129968), a potent, selective, and orally bioavailable chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) antagonistHeinz Fretz, Anja Valdenaire, Julien Pothier, et al.
The Journal of Chemical Physics|January 17, 2020
Timescale prediction of complex multi-barrier pathways using flux sampling molecular dynamics and 1D kinetic integration: Application to cellulose dehydrationPierre-Louis Valdenaire, Roland J M Pellenq, Franz J Ulm, et al.
Pageof 7